PMV Pharmaceuticals snags $70m Series D

Cranbury, New Jersey-based PMV Pharmaceuticals, Inc., a precision oncology company, has closed $70 million in Series D financing.

3 August 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles